Re: Farmas USA
Re: Farmas USA
Re: Farmas USA
HEB
HEMISPHERX BIOPHARMA ANNOUNCES FINANCIAL RESULTS FOR THE
THREE MONTHS ENDED MARCH 31, 2013
net loss (including non-cash effects) was approximately $3,611,000 or $(0.02) per share as compared to a net loss of $2,308,000 or ($0.02) per share for the same three month period in 2012. caused by:
an increase of approximately $671,000 related to continued efforts to seek FDA approval
approximately $95,000 in higher non-cash stock compensation to strategic consultants supporting the overall Ampligen® commercialization effort;
and a decrease of approximately $642,000 from sales of New Jersey State Net Operating Loss carry forwards.
Cash, cash equivalents and marketable securities were approximately $37,835,000 at March 31, 2013 as compared to $43,953,000 as of December 31, 2012.
Re: Farmas USA
CLSN
El señor director Link Max se compra 45000 acciones a 0,97
Y la señora directora Chow Pok Yu Augustine 35000 a 0,97
Edito: y han llegado 3 más. Todos comprando.
http://investor.celsion.com/secfiling.cfm?filingid=749647-13-4
http://investor.celsion.com/secfiling.cfm?filingid=749647-13-5
Re: Farmas USA
No os resulta extraño que el sell-off de ayer fuera RETAIL a saco y el de hoy institucional ( ademas de retail) ???
Desde cuando este es el orden de las cosas en el universo!!!
Desde cuando los retail saltan primero del barco???
Vaya expediente X!!
SNTA